Literature DB >> 23165827

Successful treatment of bullous pemphigoid with omalizumab.

Vanessa A London, Gene H Kim, Janet A Fairley, David T Woodley.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23165827     DOI： 10.1001/archdermatol.2012.1604

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  19 in total

Review 1.  Off-Label Uses of Omalizumab.

Authors:  David El-Qutob
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 2.  Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management.

Authors:  Minhee Kim; Luca Borradori; Dédée F Murrell
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

Review 3.  Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid.

Authors:  K A N Messingham; H M Holahan; J A Fairley
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

4.  [Bullous pemphigoid].

Authors:  F Schulze; M Kasperkiewicz; D Zillikens; E Schmidt
Journal:  Hautarzt       Date:  2013-12       Impact factor: 0.751

5.  [Bullous pemphigoid: a new look at a well-known disease].

Authors:  G Balakirski; H F Merk; M Megahed
Journal:  Hautarzt       Date:  2014-12       Impact factor: 0.751

Review 6.  A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets.

Authors:  Mohsen Afarideh; Robert Borucki; Victoria P Werth
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

7.  Omalizumab therapy for bullous pemphigoid.

Authors:  Kenneth K Yu; Ashley B Crew; Kelly A N Messingham; Janet A Fairley; David T Woodley
Journal:  J Am Acad Dermatol       Date:  2014-06-20       Impact factor: 15.487

8.  Human eosinophils express the high affinity IgE receptor, FcεRI, in bullous pemphigoid.

Authors:  Kelly N Messingham; Heather M Holahan; Alexandra S Frydman; Colleen Fullenkamp; Rupasree Srikantha; Janet A Fairley
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

Review 9.  A role for auto-immunity in chronic rhinosinusitis? Lessons learned from sub-epidermal bullous disorders of the skin.

Authors:  Philippe Lefrançois; Hugo Chapdelaine; Benoît Côté; Martin Desrosiers
Journal:  Allergy Asthma Clin Immunol       Date:  2016-08-05       Impact factor: 3.406

Review 10.  IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.

Authors:  Arnau Navinés-Ferrer; Eva Serrano-Candelas; Gustavo-J Molina-Molina; Margarita Martín
Journal:  J Immunol Res       Date:  2016-12-21       Impact factor: 4.818
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.